Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 2 Triple Negative Breast Neoplasms 1 Smoldering Multiple Myeloma 1 Sarcoma 1 Myelodysplastic Syndromes 1 Metastasis From Malignant Tumor of Kidney (Disorder) 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Carboplatin 330 Pemetrexed 266 Cisplatin 234 Docetaxel 195 Paclitaxel 182 Radiotherapy 181 Erlotinib Hydrochloride 153 pembrolizumab 147 Gemcitabine 147 Bevacizumab 125 Drug Therapy 121 Radiosurgery 115 Nivolumab 112 osimertinib 92 durvalumab 88 Gefitinib 67 atezolizumab 63 Vinorelbine 63 Surgical Procedures, Operative 62 Magnetic Resonance Spectroscopy 54 anlotinib 42 Immunotherapy 42 Taxes 39 Blood Specimen Collection 39 Ipilimumab 38 130-nm albumin-bound paclitaxel 38 Specimen Handling 36 Immune Checkpoint Inhibitors 35 Radiation 34 Albumin-Bound Paclitaxel 33

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Non-Small-Cell Lung × Immunotherapy, Active × Clear all

NCT05129202 2023-04-10

OMESIA

Hunan Province Tumor Hospital

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡